Home/Filings/4/0001567619-21-002144
4//SEC Filing

Vexler Vladimir 4

Accession 0001567619-21-002144

CIK 0001512762other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 5:39 PM ET

Size

5.7 KB

Accession

0001567619-21-002144

Insider Transaction Report

Form 4
Period: 2021-02-01
Vexler Vladimir
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-01+50,00050,000 total
    Exercise: $17.60From: 2021-02-01Exp: 2031-02-01Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]On January 22, 2021, the compensation committee of the board of directors of Coherus BioSciences, Inc. approved the grant of an option to purchase 50,000 shares of common stock subject to the achievement of a certain performance milestone. 100% of the shares underlying this option were fully vested and exercisable at grant.

Documents

1 file

Issuer

Coherus BioSciences, Inc.

CIK 0001512762

Entity typeother

Related Parties

1
  • filerCIK 0001759506

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:39 PM ET
Size
5.7 KB